Research and Markets: Gain Insight into Operations and Product Lines at ACI Global Corp

Business Wire, March 29, 2007

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c52866) has announced the addition of ACI Global Corp - Competitor Report to their offering.

The ACI Global Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The ACI Global Corp Competitor report therefore delivers the latest and the most comprehensive intelligence available on the key companies active within ACI Global Corps markets.

Competitor
 Business Summary
 Contact Information
 Selected Financial Data
 Company Details
 Product Glance (Table/Graph)
 Disease Hub Classification (Table/Graph)
 Product Pipeline
 Products
 Competitor Details by Therapeutic Indication
 Recent Updates
 Sample Screenshot

For more information visit http://www.researchandmarkets.com/reports/c52866